ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 113497 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 113497; 2) Community: the network communities that were significantly associated with the response to NSC 113497; 3) Molecule: the relationships between components within communities and NSC 113497; 4) MDR: the compounds that were significantly associated with the NSC 113497.

NSC Compound Enrichment Correlation
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.022188614181866 -0.17540904
NSC 709974 Null 0.022188614181866 0.20709968
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.022188614181866 0.16577561
NSC 753661 methyl ester prodigiosene 0.022188614181866 0.2361691
NSC 90736 Null 0.022188614181866 0.1989311
NSC 191924 Null 0.0235234559682125 0.36317394
NSC 285166 Oxine 0.0235234559682125 0.35192436
NSC 376266 1-Piperazinethiocarboxylic acid, 4-(2-propynyl)- 2-[1-(2-pyridinyl)ethylidene]hydrazide 0.0235234559682125 0.29481686
NSC 632791 Platinum, dichloro[(methylsulfinyl)phenyl-S](quinoline-N)-, (SP-4-1) 0.0235234559682125 0.12402342
NSC 634784 4-Piperidinone, 1-[3-(dimethylamino)-1-oxopropyl]-3,5- bis(phenylmethylene)-, monohydrochloride 0.0235234559682125 0.49436127
Total:72  Current:37    [First] [Prev] [Next] [Last]